SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-056121
Filing Date
2023-10-30
Accepted
2023-10-30 07:25:22
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20230930.htm   iXBRL 10-Q 2564933
2 EX-31.1 dyn-ex31_1.htm EX-31.1 12994
3 EX-31.2 dyn-ex31_2.htm EX-31.2 12544
4 EX-32.1 dyn-ex32_1.htm EX-32.1 6504
5 EX-32.2 dyn-ex32_2.htm EX-32.2 6419
  Complete submission text file 0000950170-23-056121.txt   6950258

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20230930_lab.xml EX-101.LAB 301524
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20230930.xsd EX-101.SCH 30521
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dyn-20230930_cal.xml EX-101.CAL 34609
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20230930_pre.xml EX-101.PRE 212175
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dyn-20230930_def.xml EX-101.DEF 83615
47 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20230930_htm.xml XML 1159951
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 231357197
SIC: 2834 Pharmaceutical Preparations